Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
Liqiang Feng, Qian Wang, Chao Shan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 224

Showing 26-50 of 224 citing articles:

Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
Yongjun Sui, Jianping Li, Roushu Zhang, et al.
JCI Insight (2021) Vol. 6, Iss. 10
Open Access | Times Cited: 63
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters
Qingmei Jia, Helle Bielefeldt‐Ohmann, Rachel M. Maison, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 57
Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use
Deepa Vasireddy, Paavani Atluri, Srikrishna V Malayala, et al.
Journal of Clinical Medicine Research (2021) Vol. 13, Iss. 4, pp. 204-213
Open Access | Times Cited: 56
Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain
Daniela I. Staquicini, Fenny H. F. Tang, Christopher Markosian, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 30
Open Access | Times Cited: 56
Microarray patches enable the development of skin-targeted vaccines against COVID-19
Emrullah Korkmaz, Stephen C. Balmert, Tina L. Sumpter, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 164-186
Open Access | Times Cited: 55
Mucosal vaccine delivery: A focus on the breakthrough of specific barriers
Mengwen Huang, Miaomiao Zhang, Hongbin Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3456-3474
Open Access | Times Cited: 52
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines
Violette Mouro, Alain Fischer
Mucosal Immunology (2022) Vol. 15, Iss. 4, pp. 584-594
Open Access | Times Cited: 51
SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
Ping He, Banghui Liu, Xijie Gao, et al.
Nature Microbiology (2022) Vol. 7, Iss. 10, pp. 1635-1649
Open Access | Times Cited: 50
Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques
Fang Xu, Shipo Wu, Linan Yi, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 439-442
Open Access | Times Cited: 42
A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine
Wenming Liu, Hengchun Li, Bo Liu, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 23
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 9
Development of NP-Based Universal Vaccine for Influenza A Viruses
Ekramy E. Sayedahmed, Nelly O. Elshafie, Andrea Pires dos Santos, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 157-157
Open Access | Times Cited: 8
Advances in Oral Subunit Vaccine Design
Hans Van der Weken, Eric Cox, Bert Devriendt
Vaccines (2020) Vol. 9, Iss. 1, pp. 1-1
Open Access | Times Cited: 56
Delivery Routes for COVID-19 Vaccines
Jang Hyun Park, Heung Kyu Lee
Vaccines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 54
Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Ping Yuan, Pu Ai, Yihan Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 52
Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse
Yingying Du, Yuhua Xu, Feng Jin, et al.
Vaccine (2021) Vol. 39, Iss. 16, pp. 2280-2287
Open Access | Times Cited: 52
Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19
Kenneth Lundström
Viruses (2020) Vol. 12, Iss. 11, pp. 1324-1324
Open Access | Times Cited: 50
Could live attenuated vaccines better control COVID-19?
Shinya Okamura, Hirotaka Ebina
Vaccine (2021) Vol. 39, Iss. 39, pp. 5719-5726
Open Access | Times Cited: 49
The Role of Collectivism–Individualism in Attitudes Toward Compliance and Psychological Responses During the COVID-19 Pandemic
Wen Xiao
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 47
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
Berislav Bošnjak, Ivan Odak, Joana Barros‐Martins, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques
Yuzhong Li, Yanwei Bi, Hongjian Xiao, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 342-355
Open Access | Times Cited: 43
SARS-CoV-2 in animals: From potential hosts to animal models
Anna Michelitsch, Kerstin Wernike, Lorenz Ulrich, et al.
Advances in virus research (2021), pp. 59-102
Open Access | Times Cited: 40
Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness
Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, et al.
Infectious Disorders - Drug Targets (2021) Vol. 22, Iss. 2
Closed Access | Times Cited: 40
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
Cyril Le Nouën, Christine E Nelson, Xueqiao Liu, et al.
Cell (2022) Vol. 185, Iss. 25, pp. 4811-4825.e17
Open Access | Times Cited: 31
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
Chulwoo Kim, Jae-Deog Kim, Sang‐Uk Seo
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 335-346
Open Access | Times Cited: 28

Scroll to top